| | CLASS NOTES |
| 1.1 | DF | DIFFERENTIATED TISSUE OR ORGAN OTHER THAN BLOOD, PER SE, OR DIFFERENTIATED TISSUE OR ORGAN MAINTAINING; COMPOSITION THEREFOR {2} |
| 2 | DF | MAINTAINING BLOOD OR SPERM IN A PHYSIOLOGICALLY ACTIVE STATE OR COMPOSITIONS THEREOF OR THEREFOR OR METHODS OF IN VITRO BLOOD CELL SEPARATION OR TREATMENT |
| 3 | DF | CONDITION RESPONSIVE CONTROL PROCESS |
| 4 | DF | MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP {15} |
| 41 | DF | MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION {26} |
| 440 | DF | PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION {6} |
| 173.1 | DF | TREATMENT OF MICRO-ORGANISMS OR ENZYMES WITH ELECTRICAL OR WAVE ENERGY (E.G., MAGNETISM, SONIC WAVES, ETC.) {5} |
| 174 | DF | CARRIER-BOUND OR IMMOBILIZED ENZYME OR MICROBIAL CELL; CARRIER-BOUND OR IMMOBILIZED CELL; PREPARATION THEREOF {3} |
| 183 | DF | ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES {11} |
| 235.1 | DF | VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING {2} |
| 325 | DF | ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE {17} |
| 410 | DF | PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO GENOTYPIC CHANGE OCCURS; MEDIUM THEREFORE {10} |
| 242 | DF | SPORE FORMING OR ISOLATING PROCESS |
| 243 | DF | MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR {14} |
| 320.1 | DF | VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) |
| 262 | DF | PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES {8} |
| 283.1 | DF | APPARATUS {9} |
| 317.1 | DF | MISCELLANEOUS (E.G., SUBCELLULAR PARTS OF MICRO-ORGANISMS, ETC.) |
| | ****************************** |
| | CROSS-REFERENCE ART COLLECTIONS |
| | ****************************** |
| 800 | DF | ELIMINATION OR REDUCTION OF CONTAMINATION BY UNDERSIRED FERMENTS (E.G., ASEPTIC CULTIVATION) |
| 801 | DF | ANEROBIC CULTIVATION |
| 802 | DF | LOGARITHMIC GROWTH PHASE |
| 803 | DF | PHYSICAL RECOVERY METHODS (E.G., CHROMATOGRAPHY, GRINDING) |
| 804 | DF | SINGLE CELL PROTEIN |
| 805 | DF | TEST PAPERS |
| 806 | DF | FERTILITY TESTS |
| 807 | DF | GAS DETECTION APPARATUS |
| 808 | DF | OPTICAL SENSING APPARATUS |
| 809 | DF | INCUBATORS OR RACKS OR HOLDERS FOR CULTURE PLATES OR CONTAINERS |
| 810 | DF | PACKAGED DEVICE OR KIT |
| 811 | DF | INTERFERON |
| 812 | DF | FOAM CONTROL |
| 813 | DF | CONTINUOUS FERMENTATION |
| 814 | DF | ENZYME SEPARATION OR PURIFICATION {2} |
| 817 | DF | ENZYME OR MICROBE ELECTRODE |
| 818 | DF | AERATION OR OXYGEN TRANSFER TECHNIQUE |
| 819 | DF | FERMENTATION VESSELS IN SERIES |
| 820 | DF | SUBCELLULAR PARTS OF MICRO-ORGANISMS |
| 821 | DF | MICRO-ORGANISMS USED IN THE DESTRUCTION OF HAZARDOUS OR TOXIC WASTE {5} |
| | ****************************** |
| | MICRO-ORGANISM CROSS-REFERENCE ART COLLECTIONS |
| | ****************************** |
| | ****************************** |
| | CROSS-REFERENCE ART COLLECTIONS |
| | RELATED TO SUBCLASSES |
| | 7.1 THROUGH 7.95 |
| | ****************************** |
| 960 | DF | IMMUNOHISTOCHEMICAL ASSAY |
| 961 | DF | INCLUDING A STEP OF FORMING, RELEASING, OR EXPOSING THE ANTIGEN OR FORMING THE HAPTEN-IMMUNOGENIC CARRIER COMPLEX OR THE ANTIGEN, PER SE |
| 962 | DF | PREVENTION OR REMOVAL OF INTERFERING MATERIALS OR REACTANTS OR OTHER TREATMENT TO ENHANCE RESULTS (E.G., DETERMINING OR PREVENTING NONSPECIFIC BINDING, ETC.) |
| 963 | DF | METHODS OF STOPPING AN ENZYME REACTION OR STABILIZING THE TEST MATERIALS |
| 964 | DF | INCLUDING ENZYME-LIGAND CONJUGATE PRODUCTION (E.G., REDUCING RATE OF NONPRODUCTIVE LINKAGE, ETC.) |
| 965 | DF | INVOLVING IDIOTYPE OR ANTI-IDIOTYPE ANTIBODY |
| 966 | DF | INVOLVING AN ENZYME SYSTEM WITH HIGH TURNOVER RATE OR COMPLEMENT MAGNIFIED ASSAY (E.G., MULTI-ENZYME SYSTEMS, ETC.) |
| 967 | DF | STANDARDS, CONTROLS, MATERIALS (E.G., VALIDATION STUDIES, BUFFER SYSTEMS, ETC.) |
| 968 | DF | HIGH ENERGY SUBSTRATES (E.G., FLUORESCENT, CHEMILUMINESCENT, RADIOACTIVE, ETC.) |
| 969 | DF | MULTIPLE LAYERING OF REACTANTS |
| 970 | DF | TEST STRIP OR TEST SLIDE |
| 971 | DF | CAPTURE OF COMPLEX AFTER ANTIGEN-ANTIBODY REACTION |
| 972 | DF | MODIFIED ANTIBODY (E.G., HYBRID, BIFUNCTIONAL, ETC.) |
| 973 | DF | SIMULTANEOUS DETERMINATION OF MORE THAN ONE ANALYTE |
| 974 | DF | AIDS RELATED TEST |
| 975 | DF | KIT |
| | ********************************* |
| | FOREIGN ART COLLECTIONS |
| | ********************************* |
| FOR 100 | DF | ANIMAL OR PLANT CELL (E.G., CELL LINES, ETC.); COMPOSITIONS THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING ANIMAL OR PLANT CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL OR PLANT CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING ANIMAL OR PLANT CELL; CULTURE MEDIA THEREFORE (435/240.1) {2} |
| FOR 123 | DF | MUTATION OR GENETIC ENGINEERING (435/172.1) {2} |
| FOR 126 | DF | OBTAINING THE DESIRED GENE; DNA, RNA PER SE AND THE MODIFICATION THEREOF OTHER THAN VECTOR MODIFICATION (935/1) {5} |
| FOR 147 | DF | VECTORS AND METHODS OF MODIFYING VECTORS (935/22) {1} |
| FOR 158 | DF | METHODS OF ENHANCING OR DIMINISHING EXPRESSION (935/33) {4} |
| FOR 177 | DF | METHODS OF INTRODUCING A GENE INTO A HOST CELL, E.G., TRANSFORMATION OR TRANSFECTION, ETC. (935/52) {3} |
| FOR 184 | DF | METHOD OF USE OF GENETICALLY ENGINEERED CELLS, E.G., OIL SPILL CLEANUP, ETC. (935/59) {5} |
| FOR 191 | DF | CELLS CONTAINING A VECTOR AND/OR EXOGENOUS GENE PER SE; PROPAGATION THEREOF; OTHER MEMBRANE ENCAPSULATED DNA, E.G., PROTOPLASTS, ETC. (935/66) {4} |
| FOR 201 | DF | ASSAY RELATED TO GENETIC ENGINEERING (935/76) {2} |
| FOR 210 | DF | GENETIC ENGINEERING APPARATUS (935/85) {2} |
| FOR 214 | DF | HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, ETC. (935/89) {4} |
| FOR 236 | DF | MISCELLANEOUS (935/111) |
